Clinical Trials Directory

Trials / Completed

CompletedNCT04170764

Clinical Utility of Postoperative Hemoglobin Testing

Clinical Utility of Postoperative Hemoglobin Testing Following Vaginal Hysterectomy and Reconstruction for Symptomatic Pelvic Organ Prolapse

Status
Completed
Phase
Study type
Observational
Enrollment
664 (actual)
Sponsor
TriHealth Inc. · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate how many patients have hemoglobin less than 10 g/dL at post-operative day 1

Detailed description

Obtaining a complete blood count (CBC) on post-operative day 1 to assess postoperative hemoglobin levels is routine practice at Cincinnati Urogynecology Associates, TriHealth Inc. after pelvic reconstructive surgery. There is minimal data supporting this practice. Multiple studies throughout the gynecology literature suggest that this is not a necessary or cost effective strategy to assess for postoperative anemia. Most patients who require blood transfusion or reoperation for bleeding will show clinical signs of anemia. The investigators aim to determine if checking a routine CBC results in clinically relevant changes to patient care in women undergoing pelvic reconstructive surgery with vaginal hysterectomy for treatment of pelvic organ prolapse.

Conditions

Timeline

Start date
2019-11-22
Primary completion
2020-05-19
Completion
2020-05-28
First posted
2019-11-20
Last updated
2023-09-01
Results posted
2023-09-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04170764. Inclusion in this directory is not an endorsement.